Morgan Stanley’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $3K | Buy |
|
|||||
|
2017
Q4 | $14K | Sell |
|
|||||
|
2017
Q3 | $62K | Buy |
|
|||||
|
2017
Q2 | $72K | Sell |
|
|||||
|
2017
Q1 | $131K | Buy |
|
|||||
|
2016
Q4 | $63K | Sell |
|
|||||
|
2016
Q3 | $1.29M | Buy |
|
|||||
|
2016
Q2 | $1.45M | Sell |
|
|||||
|
2016
Q1 | $2.3M | Buy |
|
|||||
|
2015
Q4 | $5.68M | Sell |
|
|||||
|
2015
Q3 | $8.4M | Buy |
|
|||||
|
2015
Q2 | $14.2M | Sell |
|
|||||
|
2015
Q1 | $22.8M | Buy |
|
|||||
|
2014
Q4 | $14M | Buy |
|
|||||
|
2014
Q3 | $5.34M | Buy |
|
|||||
|
2014
Q2 | $542K | Buy |
|
|||||
|
2014
Q1 | $352K | Buy |
|
|||||
|
2013
Q4 | $127K | Sell |
|
|||||
|
2013
Q3 | $200K | Sell |
|
|||||
|
2013
Q2 | $279K | Buy |
|